Immune reactivity in a mouse model of familial ALS correlates with disease progression

Neurology

Volumn 57, Issue 7, 2001, Pages 1282-1289

  Alexianu, Maria E ^a   Kozovska, Milena ^a   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; DISEASE COURSE; DISEASE MODEL; FAMILIAL DISEASE; IMMUNOREACTIVITY; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD VENTRAL HORN; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0035833937     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.7.1282     Document Type: Article

References (46)

1. Oxidative damage in neurodegenerative diseases
2. ++-ATPase by peroxinitrite
3. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes
4. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
5. Mutations in all five exons of SOD-1 may cause ALS
6. Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease
7. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis
8. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation
9. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
10. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis
11. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis
12. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis
13. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: Pathological and immunocytochemical changes
14. Experimental autoimmune motor neuron disease
15. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: Experimental autoimmune gray matter disease
16. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
17. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS
18. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)
19. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration
20. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis
21. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
22. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice
23. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis
24. Activation of microglia during developmentally regulated cell death in the cerebral cortex
25. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
26. Glial cell reactions in neurodegenerative diseases: Pathophysiology and therapeutic interventions
27. Activation of microglia: A dangerous interlude in immune function in the brain
28. Microglial-neuronal interactions in synaptic damage and recovery
29. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function
30. Immune and inflammatory responses in the CNS: Modulation by astrocytes
31. Molecular mechanisms regulating motor neuron development and degeneration
32. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
33. Peroxinitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocytes-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide
34. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis
35. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS
36. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins
37. How alpha beta T-cell receptors 'see' peptide/MHC complexes
38. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation
39. Induction of primary T cell responses by human glial cells
40. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS
41. Energetics of leukocyte integrin activation
42. Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration
43. Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats
44. Expression of intercellular adhesion molecule (ICAM-1) by a subset of astrocytes in Alzheimer disease and other degenerative neurological disorders
45. Reactions of the immune system in chronic degenerative neurological diseases
46. Intracellular adhesion molecule-1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells